ImmunityBio
IBRX----
Forecast & Rating3 analysts currently cover ImmunityBio, of which 3 give a positive rating. The average price target is $13.00, about 83.1% upside from the current price of $7.10. Coverage is limited, so the data is for reference only. Data as of Jun 3, 2026; this does not constitute investment advice.
Jun 2, 2026Price forecast
$13.0083.10%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 19, 2026
Forecast met50.4%
Stock price$7.10
Average forecast price$10.4
Highest forecast price$24
Lowest forecast price$5
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.